middle.news
How Rhythm Biosciences’ Genetype Is Transforming Breast Cancer Screening in Australia
2:28am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Rhythm Biosciences’ Genetype Is Transforming Breast Cancer Screening in Australia
2:28am on Monday 2nd of June, 2025 AEST
Key Points
Genetype wins 12-month contract with University of Melbourne
Study targets personalised breast cancer risk screening for women aged 40-59
Integration of polygenic risk scores and mammographic density in screening
Partnership accelerates Genetype’s commercial growth trajectory
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE